Nintedanib 100 mg

Nintedanib is a medication primarily used in the treatment of idiopathic pulmonary fibrosis (IPF), a progressive lung disease characterized by scarring of the lung tissue. It is also used to treat systemic sclerosis-associated interstitial lung disease (SSc-ILD).

Nintedanib belongs to a class of drugs known as tyrosine kinase inhibitors, which work by blocking the activity of certain growth factors involved in the development of fibrosis and scarring in the lungs.